Published on Pfizer: the world's largest research-based pharmaceutical company (http://www.pfizer.com)

Home > Partnering > Partnering Highlights > Partnering Highlights

Partnering Highlights

Partnering Highlights

When we think partnerships, we think diverse, bold, and inspired. It's in those partnerships where we can find an innovative medicine that saves a life. Or the licensing deal that broadens access to a critical drug. Or the technology collaboration that brings an experimental medicine to clinical trials faster. Or, even a business process that improves the way we help our customers.

Our partnerships, while individualized in scope and breadth, all offer the possibility of a healthier world. Read about some of our partnerships

Recent Partnerships

Pages

  • previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next
August 21, 2012 VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody
August 13, 2012 Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium
August 9, 2012 Nodality Enters into a Multi-Year Strategic Collaboration with Pfizer in Autoimmune Disease
July 11, 2012 Verastem Acquires Clinical-Stage FAK Inhibitor from Pfizer
May 1, 2012 Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO™
April 23, 2012 Quark Pharmaceuticals Announces Phase 2a Study of PF-04523655 (PF-655)
Printable Version
 
 

Submit Your Opportunity

callout-placeholder

Send us your innovative ideas today.

  • Get started now

Source URL: http://www.pfizer.com/partnering/partnership_highlights?page=2